CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 308 enrolled
Drug / intervention
XR-NTX +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01932801
NCT01932801Phase 2Completed
CompareCT.gov

Harm Reduction With Pharmacotherapy for Homeless Adults With Alcohol Dependence

University of Washington·interventional·Posted Aug 30, 2013·Updated May 10, 2023

In Brief

A Phase 2 clinical trial evaluating XR-NTX, Placebo, and 1 other intervention for Alcohol Use Disorder. Completed, enrolled 308 participants across 1 site.

Detailed Summary

The goal of this study is to test the efficacy of extended-release naltrexone and harm reduction counseling in reducing alcohol-related harm among homeless people with alcohol dependence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Use Disorder
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA), Alkermes, Inc.

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedAug 30, 2013
Enrollment StartAug 1, 2013
Primary CompletionOct 11, 2018
Study CompletionJun 30, 2019
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 12.8 years ago

Interventions

XR-NTXdrug

Placeboother

HRCbehavioral